The mast cell is an important target cell in the IgE-mediated allergic reaction and releases a variety of mediators upon stimulation with specific antigens.
The peritoneal mast cells of rats, which are obtained as single cells, have been widely used for studying allergic mediator release, [13] [14] [15] [16] and the cells are easily separated by density gradient centrifugation. [14] [15] [16] [17] [18] It has been noticed, however, that rat peritoneal mast cells purified by density gradient centrifugation release only a small amount of histamine upon challenge with antigen in comparison with non-purified preparations. [19] [20] [21] Contact of mast cells with purification media does not result in the reduced histamine release, but the purification itself is crucial. Furthermore, the reduction of histamine release from purified mast cells seems to be a specific phenomenon for IgE-dependent mast cell activation, and the reduced histamine release is recovered by reconstituting with non-mast cells separated from mast cells. 22) Furthermore, potentiation of mast cell histamine release by reconstitution with non-mast cells is observed in the presence of a high concentration of phosphatidylserine, suggesting that the phospholipid may not be responsible. 23) In the present study, further characterization was undertaken to elucidate the mechanism involved in the reconstitution-induced potentiation of histamine release from purified rat mast cells.
MATERIALS AND METHODS

Animals
Male Wistar rats weighing 250-300 g were used throughout. Rats were purchased from Japan SLC, Inc.
(Hamamatsu, Japan). Experiments were undertaken following a guideline for the care and use of experimental animals written by the Japanese Association for Laboratory Animal Science in 1987.
Monoclonal IgE, Antigen, Buffer and Reagents Rat monoclonal IgE against dinitrophenyl (DNP) residue was prepared by culturing an IgE producing cell line, REC, as reported previously. 22) The culture supernatant was used as a source of IgE. The titer of the IgE preparation estimated by homologous passive cutaneous anaphylaxis was 1 : 2000 or greater. DNP-conjugated bovine serum albumin (DNP-BSA) prepared according to the method described by Eisen et al. 24) was used as an antigen to elicit mast cell histamine release. The number of DNP residues introduced was 25 per BSA molecule. Tyrode solution containing HEPES and gelatin (137 mM NaCl, 2.7 mM KCl, 0.41 mM NaH 2 PO 4 , 1.6 mM CaCl 2 , 1 mM MgCl 2 , 0.1% glucose, 10 mM HEPES, 0.05% gelatin, pH 7.4) was used throughout.
Antibodies against intercellular adhesion molecule (ICAM)-1 (rat), lymphocyte function-associated antigen (LFA)-1 (rat), very late activation antigen (VLA)-1 (hamster) and VLA-6 (hamster) were donated by Dr. Tadayuki Saitoh (Kanebo Pharmaceuticals, Tokyo, Japan). Anti-rat VLA-4 monoclonal antibodies (mouse IgG2a) were generously provided by Professor Ko Okumura, Department of Immunology, Juntendo University School of Medicine, Tokyo. The highest concentration of anti-rat VLA-4 monoclonal antibodies employed was decided according to the information reported previously, 12) and ten-times higher concentrations were employed for the other monoclonal antibodies. Fibronectin (human, Boehringer Mannheim, Mannheim, Germany) and fibronectin active fragment (Peptide Institute, Inc., Osaka, Japan) were obtained commercially. Extracellular matrix protein-coated plates (Biocoat Cellware, coated with human fibronectin, mouse laminin and rat collagen) were obtained from Becton Dickinson (Bedford, MA, U.S.A.).
Purification of Mast Cells Peritoneal mast cells of rats were sensitized by an intraperitoneal injection of 2 ml of a 1/200 dilution of monoclonal IgE preparation. Two days later, rats were sacrificed under ether anesthesia, and peritoneal cells were recovered by washing the cavity with 20 ml of Tyrode solution containing 5 units/ml of heparin. Peritoneal washings containing peritoneal exudate cells (PEC) were pooled and spun down at 45ϫg for 5 min. Cells were washed 2 times with Tyrode solution by centrifugation at 45ϫg for 5 min and resuspended in a small volume of the same solution.
Mast cells were purified by density gradient centrifugation with Percoll (Pharmacia LKB Biotechnology, Uppsala, Sweden). 14, 18, 22) Ninety per cent isoosmotic Percoll was made by mixing 9 volumes of Percoll with 1 volume of a 10-fold concentration of phosphate-free Tyrode solution, and further diluted with Tyrode solution to make 60% Percoll, the density of which was 1.09. Into a plastic tube (Falcon 2018), 12 ml of the 60% Percoll was placed, and 1 ml of PEC suspension was layered over the Percoll layer. After centrifugation at 45ϫg for 15 min, cells at the bottom of the tube were collected (purified mast cells; PMC) and suspended in Tyrode solution. Non-mast cells (NMC) were also recovered from the interface between the Tyrode solution and 60% Percoll. Recovered NMC was suspended in a large amount of Tyrode solution (about 100 ml) and centrifuged at 150ϫg for 10 min to wash away Percoll.
Suspensions of PEC, PMC and NMC were then spun down and again washed 2 times with Tyrode solution by centrifugation at 45ϫg for 5 min. Finally, cells were suspended in appropriate volumes of Tyrode solution.
Mast cells were counted after staining with neutral red. Viability of cells was 97% or more as assessed by staining with trypan blue. Mast cell purity of PEC and PMC preparations was 5-10% and over 97%, respectively. The relatively high percentage of mast cells in PEC preparations may be accounted for by the repeated cell washings by the 45ϫg, 5 min centrifugation. NMC preparations contained mast cells of 0.5% or lower. Concentration of mast cells in the final reaction mixture was adjusted to 10 5 cells/ml unless otherwise indicated.
Membrane Fraction of NMC NMC was suspended at a concentration of 2ϫ10 7 /ml in 20 mM Tris-HCl buffer, pH 7.6, containing 0.25 M sucrose, and sonicated with a sonicator (Insonator 201M, Kubota, Tokyo, Japan) at 180 W for 2 min. The mixture was centrifuged at 12000ϫg, for 10 min, and the supernatant was again centrifuged at 12000ϫg, for 15 min. The supernatant was then further centrifuged at 105000ϫg, for 60 min. The pellet was washed twice with 0.15 M KCl solution by centrifugation at 105000ϫg, for 60 min. The pellet thus obtained was suspended in Tyrode solution at appropriate concentrations and used as NMC membrane fraction. Concentration of the membrane fraction was indicated as the equivalent NMC concentration.
Incubation Supernatant of NMC NMC was suspended in Tyrode solution at a concentration of 2ϫ10 7 /ml, and incubated at 37°C for 30 min. The incubation supernatant was separated by centrifugation at 350ϫg for 10 min. Concentration of the supernatant was indicated as NMC concentration derived.
Histamine Release and Assay An aliquot of the mast cell suspension was incubated in the absence or presence of NMC, NMC membrane fraction or NMC incubation supernatant at 37°C for a specified period of time. Mast cells were then stimulated by adding antigen solution, and incubated at 37°C for 15 min. The final antigen concentration was 1 mg/ml. To assess the amount of total histamine, cell associated histamine was extracted in the presence of 1.2% HClO 4 . After centrifugation at 350ϫg for 10 min, the supernatant was separated and stored at Ϫ20°C.
The released histamine was measured fluorometrically 25) by a post-column derivatization method on an automated histamine analyzing system (Tosoh Co., Ltd., Tokyo, Japan). 22, 26, 27) The retention time was 11 min. Mast cell histamine content was 20-40 mg/million cells, and spontaneous release of histamine was 3% of total histamine or lower. PEC usually released 10-30% of total histamine upon challenge with 1 mg/ml DNP-BSA under our present experimental conditions. Duplicated experiments with the same or similar design were repeated at least two times. In each experiment, PEC, PMC, NMC, NMC membrane fraction and incubation supernatant were prepared from a single peritoneal cell pool.
Statistics In some experiments, results were expressed as the meanϮS.E.M. Statistical significance of the difference between two experimental groups was evaluated by Student's t test or Welch's t test using InStat Program (GraphPad Software, San Diego, CA, U.S.A.). Two-tailed p values are indicated.
RESULTS
Potentiation of Histamine
Release from PMC by Reconstitution with NMC Effect of NMC reconstitution on antigen-induced histamine release from PMC was examined. PEC, PMC and PMC mixed with NMC (final 2ϫ10 6 /ml) were incubated for 30 min before antigen stimulation. Results are shown in Fig. 1A . PEC and PMC released 27.5% and 9.4% of total histamine upon antigen stimulation, respectively. The reduced histamine release from PMC was po- tentiated to 38.0% by 30 min-preincubation with NMC. In contrast, an increasing concentration of mast cells did not alter the histamine release (Fig. 1B) . Similar results were obtained using different mast cell concentrations in separate experiments (data not shown). The potentiation of PMC histamine release was dependent on the reconstituted NMC concentration, and the maximum potentiation was achieved after 30 min-preincubation of PMC with NMC (Fig. 2) .
Effect of NMC Membrane Fraction on Antigen-Induced Histamine Release from PMC PMC was mixed with 2ϫ10 6 /ml NMC-equivalent membrane fraction and incubated for 30 min before antigen challenge. PEC and PMC in the absence or presence of NMC (final 2ϫ10 6 /ml) were also incubated for 30 min. As shown in Fig. 3 , PEC, PMC and NMC-reconstituted PMC released 21.7, 9.6 and 31.9% of total histamine, respectively. PMC incubated with NMC membrane fraction released 20.2% of total histamine. The potentiation of PMC histamine release by NMC membrane fraction was statistically significant. As shown in Fig. 4 , potentiation by this fraction was dose-dependent, and 5 minpreincubation of PMC with the membrane fraction was sufficient for the maximum potentiation.
Effect of NMC Incubation Supernatant on Antigen-Induced Histamine Release from PMC PEC, PMC, PMC with NMC (final 2ϫ10 6 /ml), and PMC with NMC incubation supernatant (derived from 2ϫ10 6 /ml NMC) were incubated for 30 min and then stimulated with antigen. As shown in Fig. 5A , PEC, PMC and NMC-reconstituted PMC released 20.5, 5.3 and 28.2% of total histamine, respectively. PMC incubated with NMC incubation supernatant released 15.9% of total histamine. The potentiation of PMC histamine release by NMC incubation supernatant was statistically significant.
To examine the participation of soluble factor(s) derived from NMC, PMC histamine release was investigated using Transwell (Costar). PMC and NMC were separated by polycarbonate membrane with 4 mm pores and incubated for 30 min before antigen stimulation. As shown in Fig. 5B , a tendency of potentiation was observed even when PMC and NMC were separated. The data were confirmed in separate experiments with similar experimental designs (not shown).
Effects of Antibodies against VLA-4 and Extracellular Matrix Proteins Participation of adhesion molecules in the potentiation of PMC histamine release by reconstitution with NMC was examined. Results are shown in Figs. 6 and 7. Anti-ICAM-1 (Fig. 6A) , anti-LFA-1 (Fig. 6B) , anti-VLA-1 (Fig. 6C) , anti-VLA-6 (Fig. 6D ) and anti-VLA-4 ( Fig. 7A) antibodies did not affect the potentiation of PMC histamine release by reconstitution with NMC. In extracellular matrix protein-coated plates, histamine release from PMC was not potentiated (Fig. 7B) . Neither fibronectin nor fibronectin active fragment affected the potentiation of PMC histamine release (Figs. 7C and D) .
DISCUSSION
Purified peritoneal mast cells of rats usually release a small amount of histamine upon IgE-dependent stimulation, [19] [20] [21] [22] [23] therefore, investigators have sometimes employed phosphatidylserine to potentiate the response. [28] [29] [30] Previously, we demonstrated that the low IgE-dependent histamine release from purified mast cells could be recovered or potentiated by reconstitution with separated non-mast cells. 22, 23) In the present study, we further reported that not only non-mast cells but also membrane fraction or incubation supernatant of non-mast cells could potentiate the histamine release from purified mast cells. In contrast, increasing concentration of mast cells did not affect the histamine release. Therefore, mast cell-mast cell interaction could not cause the potentiation of mast cell histamine release, but mast cell-non-mast cell interaction is crucial. Furthermore, intact cells are not essential for the potentiation if the mechanisms are identical. The potentiation of histamine release from purified mast cells caused by membrane fraction of non-mast cells was partial compared to the case of direct reconstitution with non-mast cells. In the present results, however, the amount of membrane fraction was expressed as the number of non-mast cells employed for the preparation. Therefore, a portion of the membrane fraction might have been lost during the preparation process, and this may partially explain the smaller potentiation of histamine release by membrane fraction than that by non-mast cells. Furthermore, fragmentation of the membrane structure may also reduce the activity. In the present study, we also indicated that soluble factor(s) derived from non-mast cells could potentiate the histamine release, although we were unable to demonstrate it previously. 22, 23) The difference can be explained by the incubation period employed. In our previous experiments, purified mast cells were incubated for up to 10 min in the presence of nonmast cell incubation supernatant before stimulation. In contrast, in the present experiments mast cells were preincubated with incubation supernatant of non-mast cells for 30 min. The potentiation by incubation supernatant of non-mast cells was also partial in comparison to that by non-mast cell reconstitution. In our preliminary experiment, we confirmed that supernatant of membrane fraction is also effective for potentiating histamine release (data not shown). The soluble factor(s) seems to be released spontaneously. These results suggest that an active component(s) is present on the surface of non-mast cells, and that direct contact between mast cells and non-mast cells through the active component(s), or released active component(s) participates in the potentiation of histamine release from purified mast cells. Potentiating activity of the incubation supernatant seems less potent than the membrane fraction.
As reported previously, 23) non-mast cell preparations employed in the present study contained over 80% macrophages (data not shown). The macrophage is, therefore, a candidate for cells bearing active component(s) for potentiating mast cell histamine release, although small numbers of neutrophils and eosinophils were also present in the non-mast cell preparation.
Adhesion molecules play important roles in recruitment and localization of inflammatory cells through cell-cell and cell-extracellular matrix interactions, and the expression and activation of adhesion molecules are differentially and critically regulated. Mast cells express both ICAM-1 and LFA-1 and cause homotypic aggregation through ICAM-1-LFA-1 interaction. 31) Other inflammatory cells such as macrophages and lymphocytes also express these adhesion molecules and cause heterotypic aggregation of mast cells. [32] [33] [34] Heterotypic aggregation of mast cells is reported to enhance IgE-dependent mast cell degranulation. 34) Furthermore, mast cells possess receptors for extracellular matrix proteins and attachment of mast cells to extracellular matrix causes potentiation of IgE-dependent mast cell activation. [9] [10] [11] [12] Rat peritoneal cells including mast cells are obtained as single cells and usually do not make firm aggregates unless stimulated, indicating that adhesion molecules on rat peritoneal cells seem to be regulated in inactive forms. It is suggested, therefore, that adhesion molecules are not involved in the potentiation of mast cell histamine release by non-mast cell reconstitution. Actually, antibodies against ICAM-1 and LFA-1 failed to affect the potentiation of mast cell histamine release caused by non-mast cell reconstitution, and the histamine release was not enhanced under higher concentrations of mast cells. Furthermore, receptors for extracellular matrix proteins on peritoneal cells also seem to be inactive because antibodies against VLA-1, VLA-4 and VLA-6 did not affect the potentiation of histamine release and because mast cell histamine release was not potentiated in extracellular matrix protein-coated plates. Therefore, although adhesion of mast cells to other cells or extracellular matrix could potentiate mast cell activation, the adhesion molecules examined do not seem to participate in the potentiation of mast cell histamine release by non-mast cell reconstitution.
In summary, reduced IgE-dependent histamine release from purified rat peritoneal mast cells is potentiated by nonmast cells in the rat peritoneal cavity, their membrane fraction and incubation supernatant. Interaction between mast cells and non-mast cells needs neither firm adhesion nor any prior stimulation. Although the mechanism remains to be elucidated, it may be unique.
